Relationship between folate, vitamin B₁₂, homocysteine, transaminase and mild cognitive impairment in China: a case-control study

References

• Agnew-Blais JC, Wassertheil-Smoller S, Kang JH, Hogan PE, Coker LH, Snetselaar LG, Smoller JW. 2015. Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study. J Acad Nutr Diet. 115(2):231–241.
   PubMed Web of Science ®Google Scholar
• Ai YB, Sun ZZ, Peng C, Liu LL, Xiao XQ, Li JB. 2017. Homocysteine induces hepatic steatosis involving ER stress response in high methionine diet-fed mice. Nutrients. 9(4):346.
   Web of Science ®Google Scholar
• Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, et al. 2008. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 300(15):1774–1783.
   PubMed Web of Science ®Google Scholar
• Bondi MW, Smith GE. 2014. Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology. J Int Neuropsychol Soc. 20(2):129–134.
   PubMed Web of Science ®Google Scholar
• Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, Lotterer E, Fleig W, Müller MJ. 2003. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr. 77(5):1269–1277.
   PubMed Web of Science ®Google Scholar
• Chen CH, Walker J, Momenan R, Rawlings R, Heilig M, Hommer DW. 2012. Relationship between liver function and brain shrinkage in patients with alcohol dependence. Alcohol Clin Exp Res. 36(4):625–632.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Xiao SF. 2014. Recent research about mild cognitive impairment in China. Shanghai Arch Psychiatry. 26(1):4–14.
   PubMedGoogle Scholar
• Christensen B, Refsum H, Vintermyr O, Ueland PM. 1991. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture. J Cell Physiol. 146(1):52–62.
   PubMed Web of Science ®Google Scholar
• de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. 2012. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 27(6):592–600.
   PubMed Web of Science ®Google Scholar
• Ding D, Zhao Q, Guo Q, Meng H, Wang B, Luo J, Mortimer JA, Borenstein AR, Hong Z. 2015. Prevalence of mild cognitive impairment in an urban community in China: a cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement. 11(3):300–309.e2.
   PubMed Web of Science ®Google Scholar
• Feldman H, Scheltens P, Scarpini E, Hermann N, Mesenbrink P, Mancione L, Tekin S, Lane R, Ferris S. 2004. Behavioral symptoms in mild cognitive impairment. Neurology. 62(7):1199–1201.
   PubMed Web of Science ®Google Scholar
• Garcia A, Zanibbi K. 2004. Homocysteine and cognitive function in elderly people. CMAJ. 171(8):897–904.
   PubMed Web of Science ®Google Scholar
• Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S, Frank L. 2016. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: the qualitative research phase. Alzheimers Dement. 12(1):75–84.
   PubMed Web of Science ®Google Scholar
• Guo MX, Gao L, Zhang GH, Li YM, Xu SS, Wang Z, Qu QM, Guo F. 2012. Prevalence of dementia and mild cognitive impairment in the elderly living in nursing and veteran care homes in Xi'an, China. J Neurol Sci. 312(1–2):39–44.
   PubMed Web of Science ®Google Scholar
• He Q, Li Q, Zhao JG, Wu TF, Ji L, Huang GW, Ma F. 2016. Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids Health Dis. 15(1):146.
   PubMed Web of Science ®Google Scholar
• Homocysteine Studies Collaboration. 2002. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 288:2015–2022.
   PubMed Web of Science ®Google Scholar
• Jiang B, Chen YM, Yao GE, Yao CS, Zhao HM, Jia XD, Zhang YY, Ge JL, Qiu EC, Ding CY. 2014. Effects of differences in serum total homocysteine, folate, and vitamin B12 on cognitive impairment in stroke patients. BMC Neurol. 14:217
   PubMedGoogle Scholar
• Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, Joshi S, Mahadik S. 2010. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res. 175(1–2):47–53.
   PubMed Web of Science ®Google Scholar
• Kamada Y, Hashimoto R, Yamamori H, Yasuda Y, Takehara T, Fujita Y, Hashimoto K, Miyoshi E. 2016. Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects. BBA Clin. 5:101–107.
   PubMed Web of Science ®Google Scholar
• Kim G, Kim H, Kim KN, Son JI, Kim SY, Tamura T, Chang N. 2013. Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey. J Alzheimers Dis. 33(3):853–862.
   PubMed Web of Science ®Google Scholar
• Li X, Ma C, Zhang JY, Liang Y, Chen YJ, Chen KW, Wang J, Zhang ZJ, Wang YY. 2013. Prevalence of and potential risk factors for mild cognitive impairment in community-dwelling residents of Beijing. J Am Geriatr Soc. 61(12):2111–2119.
   PubMed Web of Science ®Google Scholar
• Liu M, He Y, Jiang B, Wu L, Wang JH, Yang SS, Wang YY. 2015. Association between metabolic syndrome and mild cognitive impairment and its age difference in a Chinese community elderly population. Clin Endocrinol. 82(6):844–853.
   PubMed Web of Science ®Google Scholar
• Ma F, Wu TF, Zhao JG, Han F, Marseglia A, Liu H, Huang GW. 2016. Effects of 6-month folic acid supplementation on cognitive function and blood biomarkers in mild cognitive impairment: a randomized controlled trial in china. GERONA. 71(10):1376–1383.
   Google Scholar
• Matté C, Scherer EB, Stefanello FM, Barschak AG, Vargas CR, Netto CA, Wyse AT. 2007. Concurrent folate treatment prevents Na+,K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development. Int J Dev Neurosci. 25(8):545–552.
   PubMed Web of Science ®Google Scholar
• Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L. 2001. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 58(3):397–405.
   PubMedGoogle Scholar
• Ng TP, Feng L, Nyunt MS, Feng L, Gao Q, Lim ML, Collinson SL, Chong MS, Lim WS, Lee TS, et al. 2016. Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia: follow-up of the Singapore longitudinal ageing study cohort. JAMA Neurol. 73(4):456–463.
   PubMed Web of Science ®Google Scholar
• Ni J, Zhang L, Zhou T, Xu WJ, Xue JL, Cao N, Wang X. 2017. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province. China J Chin Med Assoc. 80(3):147–153.
   PubMed Web of Science ®Google Scholar
• Okumura K, Tsukamoto H. 2011. Folate in smokers. Clin Chim Acta. 412(7–8):521–526.
   PubMed Web of Science ®Google Scholar
• Pastore A, Alisi A, di Giovamberardino G, Crudele A, Ceccarelli S, Panera N, Dionisi-Vici C, Nobili V. 2014. Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage. Int J Mol Sci. 15(11):21202–21214.
   PubMed Web of Science ®Google Scholar
• Perneczky R, Pohl C, Sorg C, Hartmann J, Komossa K, Alexopoulos P, Wagenpfeil S, Kurz A. 2006. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues. Age Ageing. 35(3):240–245.
   PubMed Web of Science ®Google Scholar
• Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. 1994. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr. 60(4):559–566.
   PubMed Web of Science ®Google Scholar
• Pratt DS, Kaplan MM. 2000. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 342(17):1266–1271.
   PubMed Web of Science ®Google Scholar
• Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, et al. 2004. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 50(1):3–32.
   PubMed Web of Science ®Google Scholar
• Ritchie K, Artero S, Touchon J. 2001. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology. 56(1):37–42.
   PubMed Web of Science ®Google Scholar
• Sala I, Belén SM, Molina-Porcel L, Lázaro E, Gich I, Clarimón J, Blanco-Vaca F, Blesa R, Gómez-Isla T, Lleó A. 2008. Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Dement Geriatr Cogn Disord. 26(6):506–512.
   PubMed Web of Science ®Google Scholar
• Setién-Suero E, Suárez-Pinilla M, Suárez-Pinilla P, Crespo-Facorro B, Ayesa-Arriola R. 2016. Homocysteine and cognition: a systematic review of 111 studies. Neurosci Biobehav Rev. 69:280–298.
   PubMed Web of Science ®Google Scholar
• Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H. 2010. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 5(9):e12244.
   PubMed Web of Science ®Google Scholar
• Song ZY, Zhou ZX, Deaciuc I, Chen T, McClain CJ. 2008. Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology. 47(3):867–879.
   PubMed Web of Science ®Google Scholar
• Stead LM, Brosnan ME, Brosnan JT. 2000. Characterization of homocysteine metabolism in the rat liver. Biochem J. 350 Pt 3:685–692.
   PubMed Web of Science ®Google Scholar
• Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA. 2003. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 34(3):632–636.
   PubMed Web of Science ®Google Scholar
• van Beek JH, de Moor MH, de Geus EJ, Lubke GH, Vink JM, Willemsen G, Boomsma DI. 2013. The genetic architecture of liver enzyme levels: GGT, ALT and AST. Behav Genet. 43(4):329–339.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu XY, Feng CH, Li YL, Ge X, Zong GL, Wang YB, Feng B, Zhang P. 2015. Patients with type 2 diabetes exhibit cognitive impairment with changes of metabolite concentration in the left hippocampus. Metab Brain Dis. 30(4):1027–1034.
   PubMed Web of Science ®Google Scholar
• Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, et al. 2001. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 107(10):1263–1273.
   PubMed Web of Science ®Google Scholar
• Working Group on Obesity in China. 2004. Guidelines for prevention and control of overweight and obesity in chinese adults. Acta Nutrimenta Sinica. 26:1–4.
   Google Scholar
• Xiong Y, Miao RJ, Wang QQ, Zhou L, Gao L, Ma F. 2013. Prevalence and influencing factors of MCI among community elderly in Tianjin city. Chin J Public Health. 29:1–4.
   Google Scholar